Synthetic Human α-Atrial Natriuretic Peptide Improves the Management of Postoperative Hypertension and Renal Dysfunction after the Repair of Abdominal Aortic Aneurysm

    loading  Checking for direct PDF access through Ovid


ObjectiveDelayed hypertension (HT) and renal dysfunction (RD) are observed after aortic operations accompanied by infra-renal aortic cross-clamping (AXC). Atrial natriuretic peptide (ANP) has effects on vasodilation and renal protection, and we examined the hypothesis that synthetic human α-ANP (hANP) improves the postoperative management for abdominal aortic aneurysm (AAA).MethodsFifty patients undergoing elective aneurysmectomy for infrarenal-AAA between 1998 and 2001 (M:F = 43:7, mean age 70.5 ± 7.7 years) were randomly allocated to one of 2 groups; Group H (n = 24) received hANP immediately after operation (initial dose: 0.025 μg/kg/min), and Group C (n = 26) served as a control group.ResultsAll patients in Group C required nicardipine hydrochloride (4.41 ± 1.68 mg/h) for prevention of postoperative HT, whereas only 6 patients in Group H required the increase in hANP dose due to HT (P < 0.0001). Maximum hANP dose was 0.035 ± 0.019 μg/kg/min. Group H showed significantly smaller furosemide dosage in the initial 3 days (H vs. C; 9.2 ± 11.0 vs. 58.8 ± 41.5 mg, P < 0.0001), significantly lower peak-Crn (H vs. C; 1.16 ± 0.53 vs. 2.58 ± 1.42 mg/dL, P < 0.0001), and significantly lower plasma renin-activity (7.09 ± 2.38 vs. 11.52 ± 4.89 ng/mL/h, P = 0.0002) and aldosterone (51.6 ± 12.7 vs. 81.2 ± 34.2 pg/mL, P = 0.0002) on the first postoperative day than Group C did.ConclusionsThese results imply that renin-angiotensin system may play a role in the incidence of postoperative HT and RD, and suggest that hANP infusion is a simple, reliable, and effective method for management during the immediate period after AAA operations.

    loading  Loading Related Articles